Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
Quick Stats
Feb 02, 202654.0
AI Score
HOLD0.61
Volume Ratio
Feb 25, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
TSHA Stock Summary
Last updated Feb 02, 2026
TSHA is currently trading at $4.66, positioned above its 200-day moving average of $3.58, indicating a long-term uptrend. The stock has a 52-week range of $1.05 to $6.02.
Technical Analysis: The 50-day moving average stands at $5.04, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.51, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.042, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TSHA at 54.0/100 with a HOLD recommendation.
TSHA (Taysha Gene Therapies, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.51 |
| CMF (20) | -0.042 |
| ROC (10) | 2.418 |
| ADX (14) | 16.4 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.161 |
| AROONOSC (14) | -21.429 |
| WILLAMS %R (14) | -66.242 |
| MFI (14) | 35.098 |
TSHA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TSHA Price vs Max Options Open Interest
TSHA Max Change In Options Open Interest
TSHA Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TSHA Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TSHA Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TSHA Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Taysha Gene Therapies, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TSHA Moving Averages Analysis
Taysha Gene Therapies, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
TSHA (Taysha Gene Therapies, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 4.69 |
| 20 | 4.84 |
| 30 | 5.1 |
| 50 | 5.04 |
| 100 | 4.59 |
| 200 | 3.58 |
TSHA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.2 billion |
| Earnings/Share ($) | -0.33 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.3367 |
| EPS Estimate Next Year ($) | -0.438 |
| WallStreet Target Price ($) | 11 |
| Most Recent Quarter |